Logo

Black Communities and the Search for COVID-19 Vaccines - Shared screen with speaker view
Adrianna Boulin, she/her
01:03:41
We are not
Michael Curry
01:43:24
I want to acknowledge and thank the Mass Health Council and David Martin for making the prioritization of a COVID-19 vaccine for communities of color, disparately impacted by this disease, a focus for MHA!
Bisola Ojikutu
01:52:09
https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200819-vaccine-allocation.pdf
Michael Curry
02:01:12
Race and 1918 Influenza Pandemic in the United States: A Review of the Literature https://www,ncbi.nlm.nih.gov/pmc/articles/PMC6678782/
Michael Curry
02:04:22
@Sarah Hart Thank you for being willing to participate in the trial, as it was mentioned earlier the selflessness of that decision! I am planning to be very involved of encouraging broad participation, and targeted participation in the trials, and we should be utilizing CHWs with cultural competent ed. I also have to reach a level of confidence as well that I'm directing them to a safe trial, and "Operation Warp Speed" is concerning!
Michael Curry
02:04:49
"involved in..."
Michael Curry
02:07:58
We must address black, brown mistrust of COVID-19 vaccine https://commonwealthmagazine.org/opinion/we-must-address-black-brown-mistrust-of-covid-19-vaccine/
Katy Stephenson
02:08:45
Thanks @Sarah Hart and others for your great comments!
Gary Daffin
02:13:22
https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200709-The-Publics-Role-in-COVID-19-Vaccination.pdf
Bisola Ojikutu
02:15:00
That's great David. Will these be directed toward Black and Latinx individuals? How can we help? It would be great to get physicians of color involved.
Rajesh Gandhi
02:19:02
https://shorensteincenter.org/wp-content/uploads/2020/06/Canaries-in-the-Coal-Mine-Shorenstein-Center-June-2020.pdf
Michael Curry
02:22:45
@Sarah Hart Want to acknowledge your confidence in doctors/researchers over the government involvement in the development of the vaccine. However, there is equally as much distrust in business and Pharma, and the Pfizer in Nigeria example I gave earlier (1996 meningitis) and their having to pay out a settlement. Or, IOM's Unequal Treatment that confirmed disparate treatment, and that distrust may carry over to docs on the research side. I am looking forward to helping to move us beyond that distrust, but as I said we have to start with acknowledging that history...and our health care system is not unified on that point. We can move past it, but "nothing can be solved that can't be faced" as W.E.B. DuBois once said.
Adrianna Boulin, she/her
02:24:41
Yes it will be sent :-)
Irvienne Goldson
02:26:00
2mins
Michael Curry
02:27:05
Dr. Bisola Ojikutu, CFAR, Wanda and everyone, thank you for having us!